Jack In The Box Inc
10 nominees · 5 ballot items · contested.
Election of directors (opposed and unopposed nominees); Ratification of KPMG as independent auditors; Advisory 'Say on Pay' for named executive officer compensation; Approval of amendment to 2023 Omnibus Incentive Plan to increase shares available; Ratification of the Board’s Stockholder Protection Rights Agreement (poison pill).
Follow how the vote landed and what changed on Jack In The Box Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot5
- 1
Election of Directors
ManagementBoard: AGAINSTVote on election of ten director nominees, with Biglari Capital urging shareholders to vote AGAINST Chairman David Goebel and making no recommendation on other nominees; majority of votes cast standard applies.
More detail
The proposal asks shareholders to elect ten directors at the Annual Meeting; Biglari is specifically soliciting votes against the re-election of Chairman David Goebel while making no recommendation for the other nine nominees. Biglari seeks to use the uncontested majority-vote standard and the company’s director resignation policy to force accountability if Mr. Goebel receives more 'against' votes than 'for' votes, which would require him to tender his resignation for the Board’s consideration. Management (the Company) nominated all ten directors; Biglari’s solicitation is an oppositional proxy effort rather than a competing slate. The context includes Biglari’s view that the Board’s long-tenured members have overseen strategic missteps (notably the Del Taco acquisition and sale at a significant loss) and years of shareholder value destruction, motivating the targeted opposition to the Chairman. The recommendation is to vote 'AGAINST' Goebel to send a governance message; Biglari warns that even a successful vote does not preclude the Board from reappointing Mr. Goebel post-meeting under governing documents. The proposal is routine in form (director elections) but central to Biglari’s campaign to change Board composition and accountability.
- 2
Ratification of Appointment of KPMG LLP as Independent Registered Public Accountants for FY2026
ManagementBoard: FORRatify KPMG as the company's independent auditors for fiscal year ending September 27, 2026.
- 3
Advisory Vote to Approve Executive Compensation (Say on Pay
ManagementBoard: AGAINSTNon-binding advisory vote on the compensation of the company's named executive officers for fiscal year ended September 28, 2025.
More detail
This proposal requests an advisory approval of the company’s named executive officers’ compensation as disclosed in the proxy statement for the fiscal year ended September 28, 2025. Management seeks shareholder feedback on executive pay; although non-binding, the Compensation Committee will consider the vote when making future compensation decisions. Biglari recommends voting 'AGAINST' the proposal, arguing the executives have overseen significant shareholder value destruction and should not be rewarded. The vote is positioned as a mechanism for shareholders to express dissatisfaction with pay outcomes tied to poor company performance and governance; Biglari also frames the recommendation within its broader campaign to hold the Board and executives accountable.
- 4
Approval of Amendment to Jack in the Box Inc. 2023 Omnibus Incentive Plan to Increase Shares Available for Issuance
ManagementBoard: AGAINSTApprove amendment to the 2023 Omnibus Incentive Plan to add 2,260,000 new shares available for issuance for equity awards.
More detail
This proposal seeks shareholder approval to increase the authorized share reserve under the 2023 Omnibus Incentive Plan by 2,260,000 shares to enable future equity grants to employees and directors. Management views the amendment as necessary to continue granting market-competitive equity incentives; without approval, the company would lack sufficient shares to grant annual equity awards. Biglari opposes the amendment and recommends voting 'AGAINST,' arguing that management should not be rewarded after poor performance and that expanding the equity pool further entrenches current leadership. The vote has compensation and governance implications: approval dilutes existing shareholders and enables continued equity-based pay practices, while rejection would constrain the Compensation Committee’s flexibility to incentivize executives and employees.
- 5
Ratification of the Adoption by the Board of the Stockholder Protection Rights Agreement (Rights Agreement
ManagementBoard: AGAINSTRatify the Board’s adoption of a stockholder protection rights agreement (poison pill) that issues one right per outstanding share and would be exercisable under certain conditions; ratification would extend the Rights Agreement expiration date to July 1, 2028.
More detail
This proposal asks shareholders to ratify the Board’s previously adopted Stockholder Protection Rights Agreement (a poison pill) that grants transferable rights tied to each share and becomes exercisable under triggering events to protect against certain acquisitions. Management adopted the rights plan in July 2025 and amended it in September 2025; shareholder ratification would extend its term to July 1, 2028. Biglari opposes ratification, arguing the plan entrenches the Board, disenfranchises shareholders, limits the stock’s future upside by constraining potential purchasers, and reduces investor optionality. The vote has significant takeover defense and governance implications: ratification solidifies the Board’s defensive posture, while rejection could limit the Board’s ability to block an acquisition and signal shareholder preference for accountability.
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Callodine Capital Management, LP | 9.2% | 1,760,470 | $17M |
| 2 | Nantahala Capital Management, LLC | 8.1% | 1,542,715 | $15M |
| 3 | BIGLARI CAPITAL CORP. | 6.0% | 1,140,952 | $11M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 816,645 | $8M |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.6% | 696,076 | $7M |
| 6 | BlackRock, Inc. | 3.5% | 661,392 | $6M |
| 7 | LSV ASSET MANAGEMENT | 3.0% | 564,061 | $5M |
| 8 | BIGLARI CAPITAL CORP. | 2.8% | 542,700 | $5M |
| 9 | IPG Investment Advisors LLC | 2.8% | 536,296 | $5M |
| 10 | Allianz Asset Management GmbH | 2.7% | 506,397 | $5M |
Other Consumer Cyclical sector meetings6
Upcoming shareholder meetings at Jack In The Box Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Jack In The Box Inc 2026 annual meeting?
- Jack In The Box Inc (JACK) holds its 2026 annual shareholder meeting on Friday, February 27, 2026.
- What is the record date for the Jack In The Box Inc 2026 meeting?
- The record date for the Jack In The Box Inc 2026 meeting is Friday, January 2, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Jack In The Box Inc's 2026 meeting?
- The board is presenting 10 director nominees at the Jack In The Box Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Jack In The Box Inc 2026 meeting?
- Shareholders will vote on 5 proposals at the Jack In The Box Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.